Oppenheimer Starts Whitehawk Therapeutics (WHWK) at Outperform Feb 5, 2026 09:30AM
Whitehawk receives FDA clearance for cancer drug trial, submits second application Jan 8, 2026 08:05AM
Jones Trading Starts Whitehawk Therapeutics (WHWK) at Buy Dec 22, 2025 12:08PM
Jefferies Reiterates Hold Rating on Whitehawk Therapeutics (WHWK) Nov 20, 2025 04:00AM
Whitehawk Therapeutics, Inc. (WHWK) Tops Q3 EPS by 22c Nov 6, 2025 04:14PM


Oct 24, 2025 12:31PM Whitehawk Therapeutics presents data on PTK7 as cancer drug target
Oct 16, 2025 08:32AM Tempus partners with Whitehawk Therapeutics for cancer research
Aug 7, 2025 09:34AM Whitehawk Therapeutics, Inc. (WHWK) Misses Q2 EPS by 101c
May 8, 2025 07:39PM Whitehawk Therapeutics, Inc. (WHWK) Tops Q1 EPS by 218c
Mar 26, 2025 08:01AM Whitehawk Therapeutics (WHWK) Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals